Cheap drug rivals drag FTSE back

There was concern from UK investors today that pharmaceuticals may again see their profits fall, when FTSE 100 share prices took a dive, as cheaper version of big-named products may take business away from the world's largest firms. AstraZeneca was one of the largest culprits to drag the FTSE 100 down 54.8 points or 1.2% to 4702, only one day after posting the largest gain in eight months. AstraZeneca slid 64p, or 2.2%, to 2,823p after climbing 4.6% yesterday while Shire Pharmaceuticals Group dropped 20.75p, or 3.6%, to 549.75p and GlaxoSmithKline declined 9p to 1,391p, paring yes...